Dow Chemical has spun out its Pseudomonas fluorescens-based Pfenex Expression Technology for producing recombinant proteins into a new company called Pfenex Inc. The Dow Venture Capital group will retain a "significant minority share" in the new company alongside Signet Healthcare Partners. San Diego, CA-based Pfenex will focus on the human health applications of the technology.
MSN
Wednesday 9 December 2009
Dow spins out biomanufacturing technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment